24th Feb 2005 16:14
Evolutec Group PLC24 February 2005 For immediate release 24 February 2005 EVOLUTEC GROUP PLC ("Evolutec" or "the Company") Notice of Preliminary Results Evolutec Group plc (AIM: EVC), the biopharmaceutical company developing novelproducts for the treatment of allergic, inflammatory and autoimmune diseases,will announce its Preliminary Results for the eighteen months ended 31 December2004 on Wednesday 2 March 2005. An analyst briefing will be held at 10:00am at Buchanan Communications, 107Cheapside, London, EC2V 6DN, on the day of the announcement, followed by a pressbriefing at 11:30am. For any additional information please contact Buchanan Communications: Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Tim Anderson, Mary-Jane Johnson This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Nanoco